-
Document de presse | 2024.11.21
Phages, towards a targeted alternative to antibiotics
With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists – although it remains complex in...
-
News | 2022.12.27
Bicentenary of Louis Pasteur's birth: looking back on a year of commemorations
Two hundred years ago, on December 27, 1822, Louis Pasteur was born in the town of Dole, in the Jura region of France. The year 2022 was an opportunity to celebrate Louis Pasteur's scientific and cultural legacy and to give people a chance to discover – or rediscover – his life and work.
-
News | 2025.03.08
A collective effort for the Wikipedia pages of women scientists
On February 7, 2025, the Institut Pasteur and the les sans pagEs association organized their very first Editathon – a collaborative workshop on the Wikipedia encyclopedia – dedicated to women scientists. The aim of this event was to bring the contribution of scientists out of the shadows by creating and expanding Wikipedia pages. A fine collective effort with tangible...
-
Document de presse | 2025.05.29
The plague bacillus became less virulent, prolonging the duration of two major pandemics
Scientists at the Institut Pasteur and McMaster University have discovered that the evolution of a gene in the bacterium that causes bubonic plague, Yersinia pestis, may have prolonged the duration of two major pandemics. They have demonstrated that modifying the copy number of a specific virulence gene increases the length of infection in affected individuals. It is thought that this genetic...
-
Document de presse | 2020.03.19
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
Consortium to be led by the Institut Pasteur and will include Themis and the University of Pittsburgh.CEPI to provide initial US$4.9 million for consortium to develop a Covid-19 vaccine candidate based on measles-vector technology.Partnership becomes eighth Covid-19 vaccine development project that CEPI has signed since Jan 23, 2020 OSLO, NORWAY, March 19, 2020 – CEPI, the Coalition for...
-
News | 2020.11.26
Presbycusis: ultra-rare genetic mutations responsible for a quarter of cases occurring around the age of 50
Presbycusis, or age-related hearing loss, involves genetic and environmental factors. A genomic analysis can identify gene variants whose pathogenicity subsequently needs to be confirmed. As a general rule, frequent variants have little or very little effect; it is their cumulative impact in several genes that explains the impairment. Ultra-rare variants, on the other hand, have a strong impact...
-
News | 2023.03.22
The origins of SARS-CoV-2: the search goes on
Where did SARS-CoV-2 come from? How did this virus enter the human population? These questions still remain unanswered. In June 2022, a group of experts, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) commissioned by the World Health Organization (WHO), published a report on the origin of coronavirus but was unable to draw a definitive conclusion. Since then, research has...
-
Document de presse | 2023.03.29
World Autism Awareness Day: Institut Pasteur working actively with clinicians and the autism community
As we mark World Autism Awareness Day on Sunday April 2, 2023, this year the Institut Pasteur is celebrating the 20th anniversary of the discovery of the first genes associated with autism. In 2003, this discovery offered a new perspective on the neurodevelopmental disorder; today, it highlights what still needs to be done to help those affected by autism. Scientists in international consortia...
-
Article | 2019.06.20
Cancer and microbes
Identifying and combating the risk factors behind tumor development.
-
Document de presse | 2020.04.24
Development and evaluation of four serological assays to detect SARS-CoV-2 antibodies and two assays to detect neutralizing antibodies
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December 2019, COVID-19 had become a major pandemic threat. By April 12, 2020, around half of the world's population was in lockdown, with 1.8 million officially diagnosed cases. Scientists from the Institut Pasteur, the CNRS, Inserm and Université de Paris conducted a pilot study to...